TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness.

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Abstract Text:

Michel Guipponi,Stylianos Emmanuel Antonarakis,Hamish Steele Scott,Michel Guipponi,Stylianos Emmanuel Antonarakis,Hamish Steele Scott,

Recently, we and others have shown that mutations in TMPRSS3 were responsible for autosomal recessive non-syndromic hearing loss. TMPRSS3 is a member of the Type II Transmembrane Serine Protease (TTSP) family and encodes for a protease that also contains LDLRA (low-density lipoprotein receptor class A) and SRCR (scavenger receptor cysteine rich) domains. Fourteen pathogenic mutations, which occur not only in the catalytic domain but also in the LDLRA and SRCR domains, have been identified to date that cause the DFNB8/10 forms of deafness. In vitro experiments demonstrated that TMPRSS3 mutants were proteolytically inactive indicating that TMPRSS3 protease activity is critical for normal auditory function. However, how missense mutations in the LDLRA and SRCR domains affect the proteolytic activity of TMPRSS3 remains to be elucidated. Although the role of TMPRSS3 in the auditory system is currently not completely understood, it has been shown to regulate the activity of the ENaC sodium channel in vitro and could therefore participate in the regulation of sodium concentration in the cochlea. TMPRSS3 mutations are not a common cause of hereditary deafness, the elucidation of its function is nevertheless important for better understanding of hearing, and provide biological targets for therapeutic interventions.

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Publishing Authors By Initials

M Guipponi,SE Antonarakis,HS Scott,M Guipponi,SE Antonarakis,HS Scott,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Journal Published:

PUBLICATION TYPE: Review

Journal: Frontiers in bioscience : a journal and virtual li

VOLUME: 13

Page Numbers: 1557-67

Journal Abbreviation: Front. Biosci.

ISSN: 1093-4715

DAY: 1

MONTH: 01

YEAR: 2008

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Information

Number of References: 31

LANGUAGE: eng

NlmUniqueID: 9709506

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness.

AFFILIATION: Division of Medical Genetics, University Hospital of Geneva, Geneva, Switzerland. Michel.Guipponi@hcuge.ch

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Front Biosci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness Related Publications

• A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory.
• Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations.
• Analysis of the role of CovR and CovS in the dissemination of Streptococcus pyogenes in invasive skin disease.
• Antimicrobial activity of an abiotic host defense peptide mimic.
• Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.
• Cholesterol surrogates: a comparison of cholesterol and 16:0 ceramide in POPC bilayers.
• Combined Monte Carlo and molecular dynamics simulation of hydrated 18:0 sphingomyelin-cholesterol lipid bilayers.
• Comparison and Evaluation of PET/CT Image Registration.
• CovR activation of the dipeptide permease promoter (PdppA) in Group A Streptococcus.
• Disrupting the establishment of polarizing activity by teratogen exposure.
• Enhancing milk quality and yield in the dairy cow and buffalo by feeding protected nutrient supplements.
• Featural and configural face processing in adults and infants: a behavioral and electrophysiological investigation.
• Fine-tuning our knowledge of the anaerobic route to cobalamin (vitamin B12).
• Genetically engineered synthesis and structural characterization of cobalt-precorrin 5A and -5B, two new intermediates on the anaerobic pathway to vitamin B12: definition of the roles of the CbiF and CbiG enzymes.
• Genomic imprinting in plants.
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family.
• Hypersensitivity syndromes; erythema multiforme, erythema nodosum, urticaria.
• Lateral organization in lipid-cholesterol mixed bilayers.
• Mosquitoes do senesce: departure from the paradigm of constant mortality.
• Moyamoya syndrome associated with cocaine abuse. Case report.
• Novel applications of multichannel spectroscopy in pharmaceutical analysis.
• Novel pathways associated with quinone-induced stress in breast cancer cells.
• Relationships between fertility, peak milk yields and lactational persistency in dairy cows.
• Role of mRNA stability in growth phase regulation of gene expression in the group A streptococcus.
• Rumen protected conjugated linoleic acid (CLA) methyl esters decrease milk fat and increase CLA concentration in goat milk.
• Spatial and temporal patterns in the recovery of Aedes aegypti (Diptera: Culicidae) populations after insecticide treatment.
• The Role of A-Kinase Anchoring Proteins in cAMP-Mediated Signal Transduction Pathways.
• The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial.
• Unraveling the regulatory network in Streptococcus pyogenes: the global response regulator CovR represses rivR directly.
• Urea transport in bacteria: acid acclimation by gastric Helicobacter spp.